Attenuated influenza virus as a vector for mucosal immunization against HIV-1

被引：0
|
作者：
Katinger, D
Ferko, B
Katinger, H
Muster, T
Egorov, A
Romanova, J
Alexandrova, G
Palese, P
GarciaSastre, A
机构：
来源：
VACCINES 97 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES | 1997年
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：315 / 319
页数：5
相关论文
共 50 条
  • [31] The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
    Hedestam, Gunilla B. Karlsson
    Fouchier, Ron A. M.
    Phogat, Sanjay
    Burton, Dennis R.
    Sodroski, Joseph
    Wyatt, Richard T.
    NATURE REVIEWS MICROBIOLOGY, 2008, 6 (02) : 143 - 155
  • [32] Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope
    Wang, XH
    Kochetkova, I
    Haddad, A
    Hoyt, T
    Hone, DM
    Pascual, DW
    VACCINE, 2005, 23 (29) : 3836 - 3842
  • [33] Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
    Fontana, Judith M.
    Christos, Paul J.
    Michelini, Zuleika
    Negri, Donatella
    Cara, Andrea
    Salvatore, Mirella
    PLOS ONE, 2014, 9 (05):
  • [34] Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza
    Garulli, Bruno
    Di Mario, Giuseppina
    Stillitano, Maria Giuseppina
    Kawaoka, Yoshihiro
    Castrucci, Maria Rita
    VACCINE, 2014, 32 (21) : 2501 - 2506
  • [35] Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
    David K. Clarke
    David Cooper
    Michael A. Egan
    R. Michael Hendry
    Christopher L. Parks
    Stephen A. Udem
    Springer Seminars in Immunopathology, 2006, 28 : 239 - 253
  • [36] Mucosal Antibodies: Defending Epithelial Barriers against HIV-1 Invasion
    Ruprecht, Ruth M.
    Marasini, Bishal
    Thippeshappa, Rajesh
    VACCINES, 2019, 7 (04)
  • [37] Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
    Clarke, David K.
    Cooper, David
    Egan, Michael A.
    Hendry, R. Michael
    Parks, Christopher L.
    Udem, Stephen A.
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2006, 28 (03): : 239 - 253
  • [38] Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1
    Morris, KV
    Looney, DJ
    HUMAN GENE THERAPY, 2005, 16 (12) : 1463 - 1472
  • [39] Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo
    Hinkula, J
    Rollman, E
    Lundholm, P
    Benthin, R
    Okuda, K
    Wahren, B
    CELLS TISSUES ORGANS, 2004, 177 (03) : 169 - 184
  • [40] Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
    Belyakov, IM
    Derby, MA
    Ahlers, JD
    Kelsall, BL
    Earl, P
    Moss, B
    Strober, W
    Berzofsky, JA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) : 1709 - 1714
12345